Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction

Circulation

Volumn 105, Issue 2, 2002, Pages 186-193

  Neglia, Danilo ^a   Michelassi, Claudio ^a   Giovanna Trivieri, Maria ^a   Sambuceti, Gianmario ^a   Giorgetti, Assuero ^a   Pratali, Lorenza ^a   Gallopin, Michela ^a   Salvadori, Piero ^a   Sorace, Oreste ^a   Carpeggiani, Clara ^a   Poddighe, Rosa ^a   L'Abbate, Antonio ^a   Parodi, Oberdan ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Cardiomyopathy; Microcirculation; Prognosis

Indexed keywords

DIPYRIDAMOLE;

ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE BLOOD FLOW; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; STATISTICAL ANALYSIS;

CORONARY CIRCULATION; DIPYRIDAMOLE; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGIONAL BLOOD FLOW; STROKE VOLUME; SURVIVAL RATE; TOMOGRAPHY, EMISSION-COMPUTED; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 0037080528     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc0202.102119     Document Type: Article

References (28)

1. Myocardial blood flow in congestive and hypertrophic cardiomyopathy: Relationship to peak wall stress and mean wall velocity of circumferential fiber shortening
2. Myocardial blood flow distribution in patients with ischemic heart disease or dilated cardiomyopathy undergoing heart transplantation
3. Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries
4. Coronary dilatory capacity in idiopathic dilated cardiomyopathy: Analysis of 16 patients
5. Multifactorial determinants of reduced coronary flow reserve after dipyridamole in dilated cardiomyopathy
6. Dynamic limitation of coronary vasodilator reserve in patients with dilated cardiomyopathy and chest pain
7. Endothelium-dependent dilation in the coronary microvasculature is impaired in dilated cardiomyopathy
8. Coronary flow reserve in patients with dilated cardiomyopathy
9. Vasodilatory capacity of coronary resistance vessels in dilated cardiomyopathy
10. Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure
11. Simultaneous in vitro and in vivo validation of nitrogen-13 ammonia for the assessment of regional myocardial blood flow
12. Myocarditis: A histopathologic definition and classification
13. Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
14. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or non-ischemic cardiomyopathy
15. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation
16. Clinical, hemodynamic and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure
17. Risk stratification in patients with dilated cardiomyopathy: Contribution of Doppler-derived left ventricular filling
18. Differential coronary microvascular function in patients with left ventricular dysfunction of unknown cause: Implication for possible mechanism of myocardial ischemia in early stage of cardiomyopathy
19. Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy
20. Prognostic utility of myocardial blood flow assessed by N-13 ammonia positron emission tomography in patients with idiopathic dilated cardiomyopathy
21. Perfusion-contraction mismatch during inotropic stimulation in hibernating myocardium
22. Regional myocardial flow-metabolism relationship in patients with idiopathic dilated cardiomyopathy
23. Tables of the number of patients required in clinical trials using the logrank test
24. Idiopathic cardiomyopathy in the United States, 1970-1982
25. Natural history of incidentally discovered, asymptomatic idiopathic dilated cardiomyopathy
26. Dilated cardiomyopathy: A new natural history? The experience of the Italian Multicenter Cardiomyopathy Study
27. Effect of enalapril on mortality the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction